Reducing remnant cholesterol (RC) levels by at least 50% in individuals with levels >1 mmol/L (39 mg/dL) may have substantial benefits in reducing their risk of atherosclerotic cardiovascular disease (ASCVD).
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
